Quick answer: Without insurance, Zepbound costs $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg as LillyDirect vials or KwikPens refilled within 45 days, checked Oct 20, 2026. Refill later and 7.5 mg is $499, 10–15 mg $699. Lilly's list price is $499–$1,086.37 a fill.
- Year one at those prices: about $5,188 for 12 fills, plus the prescriber (our arithmetic).
- With commercial insurance that covers it: as little as $25 with Lilly's savings card (single-dose pen; capped at $100 a month).
- Medicare: no more than $50 a month for the KwikPen through the CMS GLP-1 Bridge, if eligible, until Dec 31, 2027.
- Generic: none is FDA-approved.
Zepbound price by dose (October 2026)
Lilly sells Zepbound for cash through its own pharmacy, LillyDirect, in two forms at one price ladder: the single-dose vial and the KwikPen. The price rises for the first two doses and then flattens, as long as each refill lands within 45 days of the last.
| Dose | Vial, refilled within 45 days | Vial, refilled later | KwikPen | List price |
|---|---|---|---|---|
| 2.5 mg (start) | $299 | $299 | $299 | $499–$1,086.37 |
| 5 mg | $399 | $399 | $399 | $499–$1,086.37 |
| 7.5 mg | $449 | $499 | $449 ($499 if late) | $499–$1,086.37 |
| 10 mg | $449 | $699 | $449 ($699 if late) | $499–$1,086.37 |
| 12.5 mg | $449 | $699 | $449 ($699 if late) | $499–$1,086.37 |
| 15 mg | $449 | $699 | $449 ($699 if late) | $499–$1,086.37 |
| Year one* | $5,188 (12 fills) | $5,688 staying at 7.5 mg; $7,488 going up to 15 mg | Same as the vial | $13,036.44 (12 single-dose pen fills) |
*Year one is our arithmetic, not a quote: 4 weeks at 2.5 mg, 4 weeks at 5 mg, then 10 fills at 7.5 mg, following the label's start-and-step schedule (Zepbound prescribing information). Because every dose from 7.5 to 15 mg is $449 when you refill on time, the on-time total is the same $5,188 whether you stay at 7.5 mg or step up to 15 mg. Your prescriber sets your dose. Prices exclude the prescriber visit, syringes (vial) and pen needles (KwikPen).
What does Zepbound cost without insurance in 2026?
For most people paying cash, $299 to $449 a month: the LillyDirect self-pay price for vials or the KwikPen. That is medication only. LillyDirect fills a prescription; it does not write one, so add a prescriber visit. Some telehealth platforms include the consultation fee in a quoted Zepbound price and others charge it separately, so compare the total.
The $1,086.37 figure that other sites quote is the list price of the single-dose pen, the form that pharmacies bill to insurance. LillyDirect has no self-pay price for that pen. At a retail pharmacy without insurance, ask for the cash price before you fill; it is not a Lilly price.
Every way to pay for Zepbound
The same drug costs anywhere from $25 to $1,086.37 a fill depending on how you pay. Each row is a separate route, with its terms and the date we checked it.
| How you pay | What you pay | Terms | Source |
|---|---|---|---|
| LillyDirect self-pay, single-dose vials | $299–$449 a month by dose | No insurance used. 4 vials per fill; you draw each dose with a syringe. $499–$699 at 7.5–15 mg if a refill comes after 45 days. | LillyDirect Zepbound, checked Oct 20, 2026 |
| LillyDirect self-pay, KwikPen | $299–$449 a month by dose | Same prices and 45-day rule as the vial. One pen holds 4 weekly doses; pen needles extra. | LillyDirect Zepbound, checked Oct 20, 2026 |
| Commercial insurance that covers Zepbound + savings card | As little as $25 for a 1-, 2- or 3-month fill | Single-dose pen. The card pays up to $100 a month and $1,300 a year; terms end Dec 31, 2026. | Zepbound savings terms, checked Oct 20, 2026 |
| Commercial insurance that doesn't cover it + savings card | As low as $499 a month | Single-dose pen. Same card; excludes Medicare, Medicaid and other government plans. | Zepbound savings terms, checked Oct 20, 2026 |
| Medicare Part D: GLP-1 Bridge (weight management) | No more than $50 a month | CMS program, July 1, 2026 to Dec 31, 2027. Eligible Part D members, prior authorization; KwikPen only, not vials or single-dose pens. | CMS GLP-1 Bridge, checked Oct 20, 2026 |
| Medicare Part D: sleep apnea with obesity | Your plan's copay | Part D plans may cover Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, usually with prior authorization. | Lilly coverage page, checked Oct 20, 2026 |
| Medicaid | Set by your state | States may exclude weight-loss drugs; coverage and prior authorization vary. The savings card does not apply. | Medicaid.gov, checked Oct 20, 2026 |
| List price (no discount, no insurance) | $499–$1,086.37 per fill | Lilly's list price before insurer discounts; $1,086.37 for the single-dose pen. Few people pay it. | Lilly pricing, checked Oct 20, 2026 (Lilly's list-price page shows automated readers a bot check) |
The pharmacy's checkout is the final word on price. Lilly may change its self-pay prices and card terms at any time.
How LillyDirect Self-Pay vials work
You need a prescription for Zepbound from a licensed prescriber, who sends it to LillyDirect. Lilly ships the vials or KwikPens to you, or you can pick them up at Walmart Pharmacy. Each fill is 4 weekly doses. Vials come with no needles: you buy syringes and draw the dose yourself. The KwikPen needs pen needles.
The 45-day rule matters from 7.5 mg up. Lilly calls it the Zepbound Journey Program: the $449 price applies when each refill is within 45 days of the last. A gap, such as a missed month, resets you to the regular price of $499 at 7.5 mg or $699 at 10, 12.5 and 15 mg.
Zepbound vial vs KwikPen price
At LillyDirect they cost the same at every dose. The difference is handling: the vial is one dose you draw with a syringe, while one KwikPen holds all four weekly doses. Vials and KwikPens cost less than the single-dose pen because Lilly sells them direct for cash, outside insurance; the single-dose pen is the form billed through insurance at its $1,086.37 list price, and the $25 savings card applies only to it.
Lilly first sold vials in August 2024, at $399 for 2.5 mg and $549 for 5 mg (AJMC, Aug 28, 2024). On Dec 1, 2025 it lowered them to today's $299–$449 (Reuters, Dec 1, 2025).
Zepbound with insurance: the $25 savings card
If your commercial plan covers Zepbound, Lilly's savings card can bring a 1-, 2- or 3-month fill of the single-dose pen to as little as $25. The card pays up to $100 a month and $1,300 a year, so a high copay leaves you paying the difference. If your plan does not cover it, the card brings the pen as low as $499 a month. The card excludes Medicare, Medicaid and other government plans, and its current terms end Dec 31, 2026.
Many plans exclude weight-loss drugs or require prior authorization. If you are denied, ask your prescriber about a prior authorization or medical exception. See Does Insurance Cover Wegovy & Zepbound? and How to Get a GLP-1 Covered by Insurance.
Does Medicare cover Zepbound?
Medicare Part D cannot cover a drug used only for weight loss. Since July 1, 2026, the Medicare GLP-1 Bridge lets eligible Part D members get the Zepbound KwikPen for weight management for no more than $50 a month, with prior authorization, through Dec 31, 2027; it does not cover vials or single-dose pens. Eligibility follows CMS's clinical criteria (see the CMS announcement). Separately, Part D plans may cover Zepbound for its other approved use, moderate-to-severe obstructive sleep apnea in adults with obesity, usually with prior authorization.
Does Medicaid cover Zepbound?
It depends on your state. Federal law lets state Medicaid programs exclude drugs used for weight loss, so coverage varies, and Lilly's savings card cannot be used with Medicaid. Check your state program through Medicaid.gov.
Is there a cheaper or generic version of Zepbound?
There is no generic. As of Oct 20, 2026, the FDA's database lists only Lilly's own tirzepatide products, Zepbound and Mounjaro (Drugs@FDA). The lowest-cost route to FDA-approved Zepbound without insurance is LillyDirect self-pay. For the full picture of brand prices next to each other, see Compounded vs Brand GLP-1 Cost and the cheapest GLP-1 cost comparison.
Is Zepbound cheaper than Mounjaro?
For cash pay, yes. Mounjaro contains the same active ingredient, tirzepatide, but is FDA-approved for type 2 diabetes management rather than weight management. LillyDirect sells the Mounjaro single-dose pen for $499 a month at every dose (LillyDirect Mounjaro, checked Oct 20, 2026), against $299–$449 for Zepbound vials and KwikPens; Mounjaro's list price is $1,112.16 per fill. Do not switch between these medications without guidance from your prescriber. Mounjaro's self-pay, savings-card and Medicare prices are in our Mounjaro price table.
Zepbound vs Wegovy cost comparison
Zepbound and Wegovy are priced closer than most people expect. Self-pay, Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg; the Wegovy pen is $349 a month at 0.25–2.4 mg through NovoCare, with $199 for a new patient's first 2 fills of the lowest doses through Dec 31, 2026 (checked Oct 20, 2026). Zepbound contains tirzepatide; Wegovy contains semaglutide. They are different drugs, not interchangeable. Wegovy's self-pay prices by dose, next to compounded semaglutide, are in our semaglutide cost comparison; for the clinical side, see Tirzepatide vs Semaglutide.
Why does Zepbound cost so much?
Lilly sets the list price, and no generic tirzepatide is approved to compete with it. The single-dose pen, the form billed to insurance, lists at $1,086.37 a fill. The cash vials and KwikPens are Lilly's own lower-priced channel for people paying without insurance. For who these medicines are approved for, see the NIDDK overview of obesity medications.
Will Zepbound get cheaper in 2026?
Only dated facts here: Lilly's self-pay ladder has been $299–$449 since Dec 1, 2025, and as of Oct 20, 2026 Lilly has not announced a new one. The Medicare GLP-1 Bridge started July 1, 2026. The savings card's current terms end Dec 31, 2026. No generic is approved. Anything beyond that is a forecast, and we don't print forecasts as prices.
How to get Zepbound at the lowest cost without insurance
- Use LillyDirect self-pay. Vials or the KwikPen at $299–$449 a month are Lilly's lowest published cash price.
- Refill within 45 days. From 7.5 mg up, a late refill costs $499–$699 instead of $449.
- Price the prescriber. When comparing telehealth pricing for Zepbound, add the visit or membership fee to the $299–$449; LillyDirect's price is medication only.
- Check coverage first. If a commercial plan covers Zepbound, the savings card can cut the pen to $25; on Medicare, check the GLP-1 Bridge. Paying with pre-tax money? See Can You Use HSA/FSA for a GLP-1?
Not all applicants qualify: Zepbound's label covers adults with a BMI of 30 or more, or 27 or more with a weight-related condition, and your prescriber decides. Zepbound next to Mounjaro, with insurance, Medicare and Medicaid, is in our guide to tirzepatide cost with and without insurance.
Compounded tirzepatide: not Zepbound, and not FDA-approved
Some telehealth companies sell compounded tirzepatide for less: $125 to $432 a month all-in at the starting dose across the 13 sellers in our compounded tirzepatide cost table (checked Oct 20, 2026). It is compounded, not FDA-approved, and not the same as, or therapeutically equivalent to, Zepbound; the FDA has not reviewed it for safety, effectiveness or quality (FDA's compounding overview), and Zepbound's trial results do not apply to it. If you are weighing compounded tirzepatide from a licensed 503A pharmacy, our guide on how to buy compounded tirzepatide explains the prescription, pharmacy and 2026 legal status, and Compounded Tirzepatide vs Zepbound sets the two side by side. Paying cash either way? tirzepatide with no insurance walks through the options.
Can I use FSA or HSA funds for Zepbound?
Possibly. Prescribed medication can be a medical expense under IRS Publication 502, so a Zepbound purchase may be reimbursable from an FSA or HSA. Your plan administrator decides, and some ask for a letter of medical necessity. For the details, see Can You Use HSA/FSA for a GLP-1?
Related cost guides
- GLP-1 Cost 2026: Full Pricing Guide (pillar): the GLP-1 cost guide (2026 pillar) covers every drug
- Tirzepatide Cost Without Insurance: our tirzepatide price table sorts every tirzepatide option by monthly cost
- Wegovy Cost Without Insurance
- Compounded Tirzepatide vs Zepbound: What's the Difference?
- Compounded vs Brand GLP-1 Cost
- Does Insurance Cover Wegovy & Zepbound?
- Cheapest GLP-1: Full Cost Comparison
Compare published GLP-1 prices →
Frequently asked questions
How much does Zepbound cost per month without insurance?
Through LillyDirect, Zepbound vials or KwikPens cost $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg if you refill within 45 days; refill later and 7.5 mg is $499 and 10–15 mg is $699 (checked Oct 20, 2026). Lilly's list price is $499 to $1,086.37 per fill.
How to get Zepbound at a low cost without insurance?
Buy vials or the KwikPen through LillyDirect self-pay ($299–$449 a month) and refill within 45 days so the 7.5–15 mg doses stay at $449 rather than $499–$699. Price the prescriber visit too, since LillyDirect fills prescriptions but does not write them.
Will Zepbound go down in price in 2026?
Lilly has not announced a new self-pay price for 2026; the $299–$449 ladder has applied since Dec 1, 2025, when Lilly cut the 5 mg vial from $499 to $399 and the higher doses to $449 (checked Oct 20, 2026). The savings card terms end Dec 31, 2026, so 2027 card terms may differ.
What doses does Zepbound come in?
Six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg, injected once a week. The label starts at 2.5 mg for 4 weeks, then 5 mg, stepping up 2.5 mg at a time to a 15 mg maximum if needed.
How much does each injection of Zepbound cost?
At LillyDirect self-pay prices, about $74.75 per weekly dose at 2.5 mg and $112.25 at 7.5–15 mg when you refill within 45 days (4 doses per fill).
How much are Zepbound vials through LillyDirect?
$299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5–15 mg, the same as the KwikPen. The $449 price holds only if you refill within 45 days; otherwise 7.5 mg is $499 and 10–15 mg is $699 (checked Oct 20, 2026).
Is there a generic version of Zepbound?
No. As of Oct 20, 2026, Drugs@FDA lists only Lilly's own tirzepatide products, Zepbound and Mounjaro. Compounded tirzepatide is not a generic: it is not FDA-approved and not the same as Zepbound.
How much is Zepbound with insurance?
If your commercial plan covers it, Lilly's savings card can bring the single-dose pen to as little as $25 for a 1-, 2- or 3-month fill, with savings capped at $100 a month and $1,300 a year. If the plan does not cover it, the card brings the pen as low as $499 a month.
Does insurance cover Zepbound for weight loss?
Sometimes. Many commercial plans exclude weight-loss drugs or require prior authorization with BMI and health records, so check your formulary and ask your prescriber about a prior authorization or exception if you are denied.
Does Medicare cover Zepbound?
Part D cannot cover a drug used only for weight loss, but through the Medicare GLP-1 Bridge eligible Part D members pay no more than $50 a month for the Zepbound KwikPen from July 1, 2026 to Dec 31, 2027. Part D plans may also cover Zepbound for obstructive sleep apnea with obesity, usually with prior authorization.
Is Zepbound cheaper than Wegovy?
It depends on the dose. Self-pay, Zepbound is $299 at 2.5 mg and $449 at 7.5–15 mg through LillyDirect, while the Wegovy pen is $349 a month at 0.25–2.4 mg through NovoCare after a $199 price for new patients' first 2 fills (NovoCare, checked Oct 20, 2026). They are different drugs: tirzepatide and semaglutide.
Is Zepbound cheaper than Mounjaro?
For cash pay, yes. Zepbound vials and KwikPens are $299–$449 a month through LillyDirect, while the Mounjaro single-dose pen, the same active ingredient approved for type 2 diabetes, is $499 a month at every dose there (checked Oct 20, 2026).
Why is Zepbound so expensive?
Its list price is set by Lilly with no generic competitor, and the single-dose pen insurers are billed for lists at $1,086.37 a fill. Lilly sells the vial and KwikPen for cash at $299–$449 a month, which is what most people without insurance actually pay.
Can I use HSA/FSA for Zepbound?
Often, yes: prescribed medication can count as a medical expense under IRS Publication 502, though your plan administrator decides what it reimburses and may ask for a letter of medical necessity.
The bottom line
Without insurance, Zepbound costs $299 to $449 a month through LillyDirect's vials and KwikPens, about $5,188 in year one if you refill on time, well below the $1,086.37 list price of the single-dose pen. With commercial coverage the savings card can bring the pen to $25; on Medicare, the GLP-1 Bridge caps eligible KwikPen fills at $50. There is no generic. Buying compounded tirzepatide via a licensed telehealth provider costs less, but it is not FDA-approved and is not Zepbound. Questions about coverage? See Does Insurance Cover Wegovy & Zepbound? See what licensed providers charge.
Sources & references
- LillyDirect: Zepbound self-pay vials and KwikPen, prices by dose and the 45-day refill terms (checked Oct 20, 2026)
- Eli Lilly: Zepbound pricing information (list price as of Jan 1, 2026) (checked Oct 20, 2026; the page shows automated readers a bot check)
- Eli Lilly: Zepbound savings card, coverage and Medicare terms (checked Oct 20, 2026)
- LillyDirect: Mounjaro self-pay single-dose pen (checked Oct 20, 2026)
- Zepbound (tirzepatide) prescribing information, DailyMed
- Drugs@FDA: approved tirzepatide applications (checked Oct 20, 2026)
- CMS: Medicare GLP-1 Bridge and CMS announcement of $50 monthly GLP-1 access (checked Oct 20, 2026)
- Medicaid.gov: resources for states
- NovoCare: Wegovy self-pay prices (checked Oct 20, 2026)
- FDA: Human drug compounding
- FDA: Postmarket drug safety information for patients and providers
- NIDDK: Prescription medications to treat overweight and obesity
- IRS Publication 502: Medical and Dental Expenses
- AJMC: Lilly launches discounted Zepbound single-dose vials (Aug 28, 2024); Reuters: Lilly cuts Zepbound price (Dec 1, 2025)
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company; Wegovy® is a registered trademark of Novo Nordisk A/S. Nouri is not affiliated with either company. Nouri is a publisher; it does not prescribe or sell any medication. Not medical, financial or tax advice: a licensed prescriber decides whether Zepbound fits you. Compounded tirzepatide is not FDA-approved, has not been evaluated by the FDA for safety, effectiveness or quality, and is not therapeutically equivalent to Zepbound or Mounjaro.
Disclosure: Nouri may earn a commission when you sign up with some of the providers we link to. It doesn't change what you pay or how we rank providers. No price on this page pays Nouri. Full disclosure.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Nouri is an independent publisher: it does not prescribe, review patient assessments, or sell medication. Talk to a licensed clinician before starting or changing any medication or treatment.
Compare licensed GLP-1 providers
Published cash prices side by side, with the month we checked them and a link to each provider's own site. Nouri doesn't prescribe or sell medication.